Microsoft word - lam sk.htm

Research Output List 2004-05
Dept of Medicine

Division of Gastroenterology & Hepatology

Scholarly books, monographs and chapters

Wong B.C.Y. and Xia H.H.X., Prevention of gastric cancer by Helicobacter pylori eradication, In: Sugano K, Helicobacter pylori-associated Gastric Cander - Evidence of its Carcinogenesis. Japan, Igaku-Shoin Ltd, 2004, 69-72. (Publication No. : 99186)
Journal publications

Gu Q., Wang J., Xia H.H.X., Lin M.C., He H., Zou B., Tu S., Yang Y., Liu X.G., Lam S.K., Wong R.W.M., Chan O.O., Yuen R.M.F., Kung H. and Wong B.C.Y., Activation of the Caspase-8/Bid and Bax Pathways in Aspirin-Induced Apoptosis in Gastric Cancer, Carcinogenesis. 2005, 26(3): 541-546. (Publication No. : 97452) Gu Q., Xia H.H.X., Wang W., Wang J., Wong R.W.M., Chan O.O., Yuen M.F., Lam S.K., Cheung K.L., Liu X.G. and Wong B.C.Y., Effect of Cyclo-Oxygenase Inhibitors on Helicobacter pylori Susceptibility to Metronidazole and Clarithromycin, Alimentary Pharmacology and Therapeutics. 2004, 20: 675-681. (Publication No. : 90709) Huang J., Zheng G., Hunt R.H., Wong R.W.M., Lam S.K., Karlberg J.P.E. and Wong B.C.Y., Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylorieradication treatments from those with peptic ulcer disease? A systemic review, World Journal of Gastroenterology. 2005, 11 (18): 2726-2732. (Publication No. : 98394) Huang J., Zheng G., Chan G.C.F., Karlberg J.P.E., Lam S.K. and Wong B.C.Y., Efficacy of Current Antiemetic Treatments for Preventing Delayed Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis of Randomized Controlled Trials, Clinical Research and Regulatory Affairs. 2004, 21 (3&4): 191-212. (Publication No. : 97502) Jiang X., Tu S., Cui J., Lin M.C., Xia H.H.X., Wong R.W.M., Chan O.O., Yuen M.F., Jiang S.H., Lam S.K., Kung H., Soh J.W., Weinstein I.B. and Wong B.C.Y., Antisense Targeting Protein Kinase C Alpha and Beta1 Inhibits Gastric Carcinogenesis, Cancer Research. 2004, 64: 5787-5794. (Publication No. : 91307) Ko J.K.S., Cho C.H. and Lam S.K., Adaptive cytoprotection through modulation of nitric oxide in ethanol-evoked gastritis, World Journal of Gastroenterology. 2004, 10(17): 2503-8. (Publication No. : 92310) Tu S., Cui J., Liston P., Jiang X., Xu R., Lin M.C., Zhu Y.B., Zou B., Ng S.M., Jiang S.H., Xia H.H.X., Wong R.W.M., Chan O.O., Yuen R.M.F., Lam S.K., Kung H. and Wong B.C.Y., Gene Therapy for Colon Cancer by Adeno-Associated Viral Vector-Mediated Transfer of Survivin Cys84Ala Mutant, Gastroenterology. 2005, 128: 361-375. (Publication No. : 97357) Wang W.H., Huang J., Zheng G., Wong R.W.M., Lam S.K., Karlberg J.P.E., Xia H.H.X., Fass R. and Wong B.C.Y., Is Proton Pump Inhibitor Testing an Effective Approach to Diagnose Gastroesophageal Reflux Disease in Patients With Noncardiac Chest Pain?, Archives of Internal Medicine. 2005, 165: 1222-1228. (Publication No. : 98382) Wong B.C.Y., Chan O.O., Wong K.W., Ching C.K., Wong R.W.M., Tam S., Lai K.C., Chan C.K., Yuen R.M.F. and Lam S.K., A pilot study of participation in faecal occult blood testing and screening colonoscopy after health education in Hong Kong, European Journal of Cancer Preview. 2005, 14(2): 181-184. (Publication No. : 99104) Wong R.W.M., Huang J., Xia H.H.X., Fung F.M.Y., Tong S.M., Cheung K.L., Ho Y.K., Lai K.C., Chan C.K., Chan O.O., Hui C.K., Lam S.K. and Wong B.C.Y., Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients , Journal of Gastroenterology and Hepatology. 2005, 20(6): 935-940. (Publication No. : 99103) Wong R.W.M., Lai K.C., Hui W.M., Hu H.C., Huang J., Wong Y.H., Xia H.H.X., Chan O.O., Lam S.K. and Wong B.C.Y., Pathophysiology of Gastroesophageal Reflux Diseases in ChineseRole of Transient Lower Esophageal Sphincter Relaxation and Esophageal Motor Dysfunction, American Journal of Gastroenterology. 2004, 99: 2088-2093. (Publication No. : 96447) Wong R.W.M., Xiao S.D., HU P.J., Wang W., Gu Q., Huang J., Xia H.H.X., WU S.M., LI C.J., CHEN M.H., CUI Y., Lai K.C., Hu H.C., Chan C.K., Lam S.K. and Wong B.C.Y., Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared to duodenal ulcer in Chinese, Alimentary Pharmacology and Therapeutics. 2005, 21: 73-81. (Publication No. : 97002) Wong W.M., Lai K.C., Lam K.F., Hui W.M., Huang J.Q., Xia H.H.X., Hu H.C., Lam C.L.K., Chan C.K., Lam S.K. and Wong B.C.Y., Onset and disappearance of Reflux Symptoms in a Chinese population: a one-year follow-up study, Alimentary Pharmacology and Therapeutics. 2004, 20: 803-812. (Publication No. : 103623) Xia H.H.X., Yang Y., Lam S.K., Wong R.W.M., Leung S.Y., Yuen S.T., Elia G., Wright N.A. and Wong B.C.Y., Aberrant Epithelial Expression of Trefoil Family Factor 2 and Mucin 6 in Helicobacter pylori infected gastric antrum, incisura, and body and its association with antralisation, Journal of Clinical Pathology. 2004, 57: 861-866. (Publication No. : 89846) Xia H.H.X., Wong B.C.Y., Zhang G.S., Yang Y., Wyatt J.M., Adams S., Cheung K., Lam S.K. and Talley N.J., Antralization of Gastric Incisura is Topographically Associated with Increased Gastric Epithelial Apoptosis and Proliferation, but not with CagA Seropositivity, Journal of Gastroenterology and Hepatology. 2004, 19: 1257-1263. (Publication No. : 96173) Xia H.H.X., Zhang S., Lam S.K., Lin M.C., Kung H. and Wong B.C.Y., Expression of Macrophage Migration Inhibitory Factor in Esophageal Squamous Cell Carcinoma and Effects of Bile Acids and NSAIDs, Carcinogenesis. 2005, 26(1): 11-15. (Publication No. : 97005) Xia H.H.X., Lam S.K., Chan O.O., Lin M.C., Kung H., Ogura K., Berg D.E. and Wong B.C.Y., Macrophage Migration Inhibitory Factor Stimulated by Helicobacter pylori Increases Proliferation of Gastric Epithelial Cells, World Journal of Gastroenterology. 2005, 11(13): 1946-1950. (Publication No. : 97727) Xia H.H.X., Lam S.K., Huang X.R., Wong R.W.M., Leung S.Y., Yuen S.T., Lan H.Y. and Wong B.C.Y., Helicobacter pylori Infection is Associated with Increased Expression of Macrophage Migratory Inhibitory Factor - by Epithelial Cells, T Cells, and Macrophages - in Gastric Mucosa, The Journal of Infectious Diseases. 2004, 190: 293-302. (Publication No. : 89844) Chang T.T., Lai C.L., Chien R.N., Guan R., Lim S.G., Lee C.M., Ng K.Y., Nicholls G.J., Dent J.C. and Leung N.W.Y., Four Years of Lamivudine Treatment in Chinese Patients with Chronic Hepatitis B. , Journal of Gastroenterology and Hepatology. 2004, 19: 1276-1282. (Publication No. : 97682) Hui C.K., Lai K.C., Wong R.W.M., Yuen R.M.F., Ng M.M.T., Chan C.K., Hu H.C., Cheung W.W., Lai C.L. and Wong B.C.Y., Outpatients Undergoing Therapeutic Endoscopic Retrograde Cholangiopancreatography: Six-hour Versus Overnight Observation , Journal of Gastroenterology and Hepatology. 2004, 19: 1163-1168. (Publication No. : 97683) Lai C.L., Lim S.G., Brown N.A., Zhou X.J., Lloyd D.M., Lee Y.M., Yuen R.M.F., Chao G.C. and Myers M.W., A Dose-finding Study of Once-daily Oral Telbivudine in HBeAg-positive Patients with Chronic Hepatitis B Virus Infection, Hepatology. 2004, 40: 719-726. (Publication No. : 97686) Lai C.L., Han K.H., Yoon S.K., Um S.H., Yuen R.M.F., Kim H.S., Kim H.R., Chung H.C., Kim C.R., Hsyu P., Averett D. and Kim J., Interim Report for a Phase II, Multi-centre, Dose-escalating Study of LB80380/ANA380 in Hepatitis B Patients with Lamivudine-resistant YMDD Mutant HBV, Journal of Hepatology. 2005, 42 (Suppl 2): 31. (Publication No. : 98464) Lim S.G., Lai C.L., Myers M., Yuen R.M.F., Wai C.T., Lloyd D., Pietropalolo K., Zhou X.J., Chao G. and Brown N.A., Final Results of a Phase I/II Dose Escalation Trial of Valtorcitabine in Patients with Chronic Hepatitis B, Journal of Hepatology. 2005, 42 (Suppl 2): 16. (Publication No. : 98465) Lo C.M., Fan S.T., Liu C.L., Yong B.H., Wong Y., Lau G., Lai C.L., Ng I.O.L. and Wong J., Lessons learned from one hundred right lobe living donor liver transplants, Annals of Surgery. 2004, 240(1): 151-158. (Publication No. : 90702) Mohamed R., Desmond P., Suh D.J., Amarapurkar D., Gane E., Guangbi Y., Hou J.L., Jafri W., Lai C.L., Lee C.H., Lee S.D., Lim S.G., Guan R., Phiet P.H., Piratvisuth T., Sollano J. and Wu J.C., Practical Difficulties in the Management of Hepatitis B in the Asia-Pacific Region, Journal of Gastroenterology and Hepatology. 2004, 19: 958-969. (Publication No. : 97687) Sum S.M., Wong D.K.H., Yuen R.M.F., Yuen H., Yu J., Lai C.L., Ho D. and Zhang L., Real-time PCR Assay Using Molecular Beacon for Quantitation of Hepatitis B Virus DNA, Journal of Clinical Microbiology. 2004, 42: 3438-3440. (Publication No. : 97712) Wong D.K.H., Yuen R.M.F., Tse E.W.C., Yuan H., Sum S.M., Hui C.K. and Lai C.L., Detection of Intrahepatic Hepatitis B Virus DNA and Correlation with Hepatic Necroinflammation and Fibrosis, Journal of Clinical Microbiology. 2004, 42: 3920-3924. (Publication No. : 97684) Wong D.K.H., Yuen R.M.F., Yuan H., Sum S.M., Hui C.K., Hall J. and Lai C.L., Quantitation of Covalently Closed Circular Hepatitis B Virus DNA in Chronic Hepatitis B Patients, Hepatology. 2004, 40: 727-737. (Publication No. : 97685) Yuan H., Yuen R.M.F., Wong D.K.H., Sum S.M. and Lai C.L., Clinical Evaluation of the Digene Hybrid Capture II Test and the COBAS AMPLICOR Monitor Test for Determination of Hepatitis B Virus DNA Levels, Journal of Clinical Microbiology. 2004, 42: 3513-3517. (Publication No. : 97710) Yuan H., Yuen R.M.F., Wong D.K.H., Sum S.M., Doutreloigne J., Sablon E. and Lai C.L., Determinants for the Occurrence of Acute Exacerbation of Hepatitis B Virus Infection in Chinese Patients after HBeAg Seroclearance , Journal of Clinical Microbiology. 2005, 43: 1594-1599. (Publication No. : 97680) Yuen M.F., Ng I.O.L., Fan S.T., Yuan H., Wong D.K.H., Yuen J.C.H., Sum S.M., Chan O.O. and Lai C.L., Significance of HBV DNA levels in liver histology of HBeAg and anti-HBe positive patients with chronic hepatitis B, American Journal of Gastroenterology. 2004, 99(10): 2032-2037. (Publication No. : 94873) Yuen R.M.F., Lim W.L., Chan O.O., Wong D.K.H., Sum S.M. and Lai C.L., 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children, Clinical Gastroenterology and Hepatology. 2004, 2(10): 941-5. (Publication No. : 101374) Yuen R.M.F. and Lai C.L., Adefovir dipivoxil in chronic hepatitis B infection, Expert Opinion on Pharmacotherapy. 2004, 5(11): 2361-7. (Publication No. : 101393) Yuen R.M.F., Wong D.K.H., Sum S.M., Yuan H., Yuen J.C.H., Chan O.O., Wong B.C.Y. and Lai C.L., Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection., American Journal of Gastroenterology. 2005, 100(5): 1099-103. (Publication No. : 101359) Yuen R.M.F., Sablon E., Tanaka Y., Kato T., Mizokami M., Doutreloigne J., Yuan H., Sum S.M. and Lai C.L., Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. , Journal of hepatology : the journal of the European Association for the Study of the Liver. 2004, 41(1): 119-25. (Publication No. : 101377) Yuen R.M.F., Wong D.K.H., Yuan H., Sum S.M. and Lai C.L., HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infection, Journal of Clinical Microbiology. 2004, 42(10): 4882-4. (Publication No. : 101395) Yuen R.M.F., Ip P., Ng W.K. and Lai C.L., Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)., Journal of hepatology : the journal of the European Association for the Study of the Liver. 2004, 41(4): 686-7. (Publication No. : 101376) Yuen R.M.F., Wong D.K.H., Chan C.S., Zhang Z., Yuen J.C.H. and Lai C.L., Immune Response During Immunoclearance Phase of Chinese Patients with HBV Genotypes B and C, Journal of Hepatology. 2005, 42 (Suppl 2): 152. (Publication No. : 98466) Yuen R.M.F., Hon C., Hui C.K., Siu C.W. and Lai C.L., Interferon treatment for metastatic hepatocellular carcinoma. Review Series, Hepatitis. 2004, 3: 12-3. (Publication No. : 104560) Yuen R.M.F., Chow D.H.F., Tsui K., Wong B.C.Y., Yuen J.C.H., Wong D.K.H. and Lai C.L., Liver histology of Asian patients with chronic hepatitis B on prolonged lamivudine therapy, Alimentary Pharmacology and Therapeutics. 2005, 21(7): 841-9. (Publication No. : 101363) Yuen R.M.F., Yuan H., Sablon E., Wong D.K.H., Chan O.O., Wong B.C.Y. and Lai C.L., Long-term follow-up study of Chinese patients with YMDD mutations: significance of hepatitis B virus genotypes and characteristics of biochemical flares, Journal of Clinical Microbiology. 2004, 42(9): 3932-6. (Publication No. : 101400) Yuen R.M.F., Fung S.K., Tanaka Y., Kato T., Mizokami M., Yuen J.C.H., Wong D.K.H., Yuan H., Sum S.M., Chan O.O., Wong B.C.Y. and Lai C.L., Longitudinal study of hepatitis activity and viral replication before and after HBeAg seroconversion in chronic hepatitis B patients infected with genotypes B and C., Journal of Clinical Microbiology. 2004, 42(11): 5036-40. (Publication No. : 101373) Yuen R.M.F., Yuan H., Wong D.K.H., Yuen J.C.H., Wong R.W.M., Chan O.O., Wong B.C.Y., Lai K.C. and Lai C.L., Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications., Gut. 2005, 54: 1610-1614. (Publication No. : 101352) Yuen R.M.F., Tanaka K., Mizokami M., Yuen J.C.H., Hui C.K., Wong D.K.H., Yuan H., Sum S.M., Chan O.O., Wong B.C.Y., Fan S.T. and Lai C.L., Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study, Carcinogenesis. 2004, 25(9): 1593-1598. (Publication No. : 107559) Yuen R.M.F. and Lai C.L., Serological markers of liver cancer., Best Practice & Research, Clinical Gastroenterology. 2005, 19(1): 91-9. (Publication No. : 101370) Yuen R.M.F. and Lai C.L., Treatment for hepatitis B: a public health perspective., Journal of Clinical Gastroenterology. 2004, 38(10 Suppl): 134-5. (Publication No. : 101372) Yuen R.M.F. and Lai C.L., Treatment of chronic hepatitis B, Medical Progress. 2005, 32(7): 349-56. (Publication No. : 107497) Zhang L., Chen Z., Cao Y., Yu J., Li G., Yu W., Yin N., Mei S., Li L., Balfe P., He T., Ba L., Zhang F., Lin H.H., Yuen R.M.F., Lai C.L. and Ho D.D., Molecular Characterization of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus in Paid Blood Donors and Injection Drug Users in China , Journal of Virology. 2004, 78: 13591-13599. (Publication No. : 97681) Ding H., Wand B.E., Jia J.D., Xia H.H.X., Wong B.C.Y., Zhao C.H. and Xu Y.L., Effects of octreotide on expression of L-type voltage-operated calcium channels and on intracellular Ca2+ in activated hepatic stellate cells, Chinese Medical Journal. 2004, 117(6): 913-916. (Publication No. : 99194) Fan X.M., Zheng F.S., Liu H.Y., Ma Y.H. and Wong B.C.Y., Mechanism of apoptosis induced by specific COX-2 inhibitor SC236 in gastric cancer cells , Zhonghua Zhong Liu Za Zhi (Chinese). 2005, 27(3): 145-147. (Publication No. : 99102) Kalia A., Mukhopadhyay A.K., Dailide G., Ito Y., Azuma T., Wong B.C.Y. and Berg D.E., Evolutionary dynamics of insertion sequences in Helicobacter pylori, Journal of Bacteriology. 2004, 186(22): 7508-7520. (Publication No. : 99180) Lewis A.E., Susarla R., Wong B.C.Y., Langman M.J. and Eggo M.C., Protein kinase C delta is not activated by caspase-3 and its inhibition is sufficient to induce apoptosis in the colon cancer line, COLO 205, Cellular signalling. 2005, 17(2): 253-262. (Publication No. : 99181) Ren Z., Borody T., Pang G., Dunkley M., Clancy R., Xia H.H.X., Chu K.M., Wong J. and Wong B.C.Y., Evaluation of anti-Helicobacter pylori IgG2 antibody for the diagnosis of Helicobacter pylori infection in Western and Chinese populations, Alimentary Pharmacology & Therapeutics. 2005, 21: 83-89. (Publication No. : 97204) Wong B.C.Y., Managing dyspepsia in regions with a high risk of gastric cancer, Alimentary Pharmacology and Therapeutics. 2005, 21 (Suppl 1): 19-20. (Publication No. : 99105) Wong R.W.M., Lim P. and Wong B.C.Y., Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: the FAST survey, Journal of Gastroenterology and Hepatology. 2004, 19(Suppl 3): S54-S60. (Publication No. : 99108) Wong R.W.M. and Wong B.C.Y., Colorectal Screening: Part II - Sigmoidoscopy, Colonoscopy, Double-Contrast Barium Enema and Virtual Colonoscopy, Medical Progress. 2005, 32(4): 193-197. (Publication No. : 97749) Wong R.W.M. and Wong B.C.Y., Constipation - an update, The Hong Kong Medical Diary. 2004, 9(6): 3-6. (Publication No. : 99245) Wong R.W.M. and Wong B.C.Y., Definition and diagnosis of gastroesophageal reflux disease, Journal of Gastroenterology and Hepatology. 2004, 19(Suppl 3): S26-S32. (Publication No. : 99109) Wong R.W.M., Hui W.M. and Wong B.C.Y., Diagnosis of Barrett's esophagus in the Asian population, Journal of Gastroenterology and Hepatology. 2005, 20(3): 495. (Publication No. : 99106) Wong R.W.M., Hui W.M. and Wong B.C.Y., Reply from authors, Journal of Gastroenterology and Hepatology. 2005, 20(3): 495. (Publication No. : 99244) Ye Y., Wu K.K., Shin V.Y., Bruce I.C., Wong B.C.Y. and Cho C.H., Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke, Carcinogenesis. 2005, 26, no. 4: 827-834. (Publication No. : 97554) Hui C.K., Lie A., Au W.Y., Leung A.Y.H., Ma S.Y., Cheung W.W., Zhang H., Chim C.S., Kwong Y.L., Liang R.H.S. and Lau G., A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation, Blood. 2005, 106: 464-9. (Publication No. : 100680) Hui C.K. and Lau G., Advances in immunomodulating therapy of HBV infection, Int J Med Sci. 2005, 2: 24-29. (Publication No. : 100545) Hui C.K., Bowden S., Jackson K., Au W.Y., Fong D.Y.T., Lie A.K.W., Chim J.C.S., Liang R.H.S. and Lau G., Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotheraphy, Blood. 2005, 105(6): 2616-2617. (Publication No. : 97667) Hui C.K., Lie A.K.W., Au W.Y., Ma S.Y., Leung A.Y.H., Zhang H., Sun J.Z., Cheung W.W.W., Chim J.C.S., Kwong Y.L., Liang R.H.S. and Lau G., Effectiveness of prophylactic Anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donors, American Journal of Transplantation. 2005, 5(6): 1437-45. (Publication No. : 98992) Hui C.K., Zhang H. and Lau G., Management of chronic hepatitis B in treatment-experienced patients, Gastroenterol Clin North Am. 2004, 33: 601-16. (Publication No. : 100595) Hui C.K., Sun J., Au W.Y., Lie A.K.W., Yueng Y.H., Zhang H., Lee N.P., Hou J., Liang R.H.S. and Lau G., Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area, Journal of Hepatology. 2005, 42(6): 813-9. (Publication No. : 98965) Hui C.K., Cheung B.M.Y. and Lau G., Pharmacokinetics of pitavastatin in subjects with Child-Pugh A and B cirrhosis, Br J Clin Pharmacol. 2005, 59: 291-7. (Publication No. : 100578) Hui C.K., Yu J., Au W.Y., Zhang H., Bartholomeusz A., Locarnini S., Kwong Y.L., Liang R.H.S. and Lau G., Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation, J Clin Virol. 2005, 32: 173-8. (Publication No. : 100586) Lau G., Piratvisuth T., Luo K.X., Marcellin P., Thongsawat S., Cooksley G., Gane E., Fried M.W., Chow W.C., Paik S.W., Chang W.Y., Berg T., Flisiak R., McCloud P. and Pluck N., Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B, N Engl J Med. USA, The Massachusetts Medical Society, 2005, 352: 2682-95. (Publication No. : 100536) Lau G., Treatment of immunosuppressed chronic hepatitis B patients, Med J Malaysia. 2005, 60: 57-62. (Publication No. : 111937) Lee N., Zheng N., Yang P.H., Wong O.G., Kung H.F., Luk J.M.C. and Lau G., Tumor necrosis factor-alpha-induced protein 1 and immunity to hepatitis B virus, World J Gastroenterol. 2005. (Publication No. : 111961) Liaw Y.F., Leung N., Guan R., Lau G., Merican I., McCaughan G., Gane E. and Kao J.H., Asian-Pacific Consensus statement on the management of chronic hepatitis B: A 2005 update, Liver International. 2005, 25(2): 472-89. (Publication No. : 112032) Liaw Y.F., Leung N., Guan R., Lau G., Merican I., McCaughan G., Gane E., Kao J.H. and Omata M., Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update, Liver Int. 2005, 25: 472-89. (Publication No. : 100552) Lo C.M., Fan S.T., Liu C.L., Yong B.H., Wong Y., Lau G., Lai C.L., Ng I.O.L. and Wong J., Lessons learned from one hundred right lobe living donor liver transplants, Annals of Surgery. 2004, 240(1): 151-158. (Publication No. : 90702) Lo C.M., Liu C.L., Lau G., Chan S.C., Ng I.O.L., Fan S.T. and Wong J., Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil to lamivudine (Abstract), American Journal of Transplantation. 2005, 5(Suppl): 180. (Publication No. : 99910) Luk J.M.C., Su Y.C.F., Lam C.T., Lee C.K.F., Hu M.Y., He Q., Lau G., Wong F.W.S. and Fan S.T., Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma, Proteomics. 2005, 5(7): 1980-1986. (Publication No. : 98403) Ma S.Y., Au W.Y., Lie A.K., Ng I.O.L., Leung A.Y.H., Tse E.W.C., Liang R.H.S., Lau G. and Kwong Y.L., Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignacies post allogeneic hematopoietic stem cell transplantation, Bone Marrow Transplant. 2004, 34: 57-61. (Publication No. : 100619) Marcellin P., Mommeja-Marin H., Sacks S.L., Lau G., Sereni D., Bronowicki J.P., Conway B., Trepo C., Blum M.R. and Yoo B.C., A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B, Hepatology. 2004, 40: 140-8. (Publication No. : 100604) Marcellin P., Lau G., Bonino F., Farci P., Hadziyannis S., Jin R., Lu Z.M., Piratvisuth T., Germanidis G. and Yurdaydin C., Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B, N Engl J Med. 2004, 351: 1206-17. (Publication No. : 100589) Ng S.S., Gao Y., Lum C.T., Yang Z., Huang J., Lau G., Fan S.T., Kung H. and Lin M.C., Novel HCC gene therapy by rAAV-mediated transfer of human TERTC27 polypeptide in human and rat hepatocellular carcinoma (Abstract), Asian Journal of Surgery. 2005, 28(Suppl 2): S99. (Publication No. : 99471) Ng S.S., Gao Y., Lum C.T., Yang Z., Lau G., Fan S.T., Kung H. and Lin M.C., rAAV-mediated long-term expression of endostatin significantly inhibits the progression of HCC (Abstract), Asian Journal of Surgery. 2005, 28(Suppl 2): S100. (Publication No. : 99476) Vandepapelière P., Lau G., Leroux-Roels G., Horsmans Y., Wettendorff M. and Ferrari C., A randomized controlled trial comparing therapeutic vaccination plus lamivudine with lamivudine only in HBeAg-positive chronic hepatitis B patients , Hepatology. 2005, in press. (Publication No. : 112047) Wang P.P., Wang J.H., Yan Z.P., Hu M., Lau G., Fan S.T. and Luk J.M.C., Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction, Biochemical and Biophysical Research Communications. 2004, 320(3): 712-716. (Publication No. : 90690) Zhang H.Y., Nanji A.A., Luk J.M.C., Huang X.R., Lo C.M., Chen Y.X., Yuen S.T., Lan H.Y. and Lau G., Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection, Liver International. 2005, 25(3): 571-579. (Publication No. : 99899) Yong J.L., Lam C.M., Chan O.O., Poon R.T.P., Liu C.L., Lo C.M. and Fan S.T., Better survival in female patients with hepatocellular carcinoma (Abstract), Asian Journal of Surgery. 2005, 28(Suppl 2): S94. (Publication No. : 99464)
Conference papers

Chan O.O., Chu K.M., Sun Y., Cheung K.L., Lam S.K., Yuen R.M.F., Hui W.M. and Wong B.C.Y., The association between Interleukin 1 beta polymorphism and hypermethylation at tumor suppressor genes in gastric cancer. Conference paper at the Annual Meeting of the American Gastroenterology Associatoin, Digestive Diseases Week (DDW) Chicago, Illinois, USA. May 14-19, Gastroenterology. 2005, 128(4 Suppl 2): A399. (Publication No. : 99435) Lai K.C., Hui W.M., Wong B.C.Y., Hu H.C., Chan O.O. and Lam S.K., Lansorprazole but not Rofecoxib reduced dyspeptic symptoms of patients on NSAIDS, Gastroenterology. 2005, 128(4 Suppl 2): A24. (Publication No. : 99428) Li G., Xia H.H.X., Chen M.H., Chan O.O., Cho C.H., Lam S.K., Berg D., Feng Z., Langenbach R. and Wong B.C.Y., Effects of Cyclooxygenase-1 and -2 Gene Disruption on Helicobacter pylori-Induced Inflammation, Apoptosis and Proliferation, Journal of Gastroenterology and Hepatology. 2004, 19(Suppl.): A299. (Publication No. : 96322) Wang J., Zou B., Gu Q., Jiang B., Zhuang Z., Xia H.H.X., Lin M.C., Lam S.K., Kung H. and Wong B.C.Y., Down-regulation of XAF1 expression by its interacting protein FHL2 via p53-mediated transcription regulation, Gastroenterology. 2005, 128(4 Suppl 2): A105. (Publication No. : 99443) Wang J., Gu Q., He H., Jiang B., Zhuang Z., Xia H.H.X., Lin M.C., Lam S.K., Kung H. and Wong B.C.Y., Down-regulation of XIAP associated factor 1 (XAF1) through Hsf-1 binding in the promoter region, Gastroenterology. 2005, 128(4 Suppl 2): A105. (Publication No. : 99446) Xia B., Xia H.H.X., Lam S.K., Chan O.O., Lai K.C., Hu H.C. and Wong B.C.Y., Trends in prevalence of peptic ulcer disease and Helicobacter pylori infection and frequency of NSAID intake in general practitioner-referred dyspeptic patients over 6 years in Hong Kong, Gastroenterology. 2005, 128(4 Suppl 2): A230. (Publication No. : 99452) Xia H.H.X., Li G., Chen M.H., Chan O.O., Cho C.H., Lam S.K., Berg D., Feng Z., Langenbach R. and Wong B.C.Y., Cyclooxygenase-1 and -2 Gene Disruption Potentiate TH1 Polarization in Response to Helicobacter pylori, Journal of Gastroenterology and Hepatology. 2004, 19(Suppl.): A366. (Publication No. : 96323) Zhu S., Xia H.H.X., Lam S.K., Yu L., Yang Y., Sun Y., Wang J., Chan O.O. and Wong B.C.Y., Alterations of gastric homeoprotein expression in H. Pylori infection and/or intestinal metaplasia, Gastroenterology. 2005, 128(4 Suppl 2): A598. (Publication No. : 99451) Zhuang Z., Tsao G.S.W., Xia H.H.X., He H., Chan O.O., Lam S.K. and Wong B.C.Y., COX-2 inhibition induces apoptosis in human esophageal epithelial cells: implication for chemoprevention, Gastroenterology. 2005, 128(4 Suppl 2): A299. (Publication No. : 99455) Lai C.L., Double-Blind, Placebo-Controlled Trial of Emtricitabine (FTC, Emtriva®) Administered Once-Daily for Treatment of Chronic Hepatitis B Virus (HBV) Infection, 55th Annual Meeting of the American Association for the Study of Liver Disease. 2004. (Publication No. : 101796) Lai C.L., Phase II Multi-center, Dose-escalating Study of LB80380(ANA380) in Hepatitis B Patients with Lamivudine-resistant YMDD Mutant HBV, 40th Annual Meeting of the European Association for the Study of the Liver. 2005. (Publication No. : 101825) Lai C.L., Phase IIb Extended-Treatment Trial of Telbivudine (LdT) vs. Lamivudine vs. Combination Treatment in Hepatitis B Patients: Two-Year Results, Digestive Disease Week. 2005. (Publication No. : 101828) Lai C.L., Brown N.A., Yuen R.M.F., Wai C.T., Lloyd D., Pietropaolo K., Zhou X.J., Chao G. and Lim S.G., Valtorcitabine provides potent suppression of hepatitis B virus in patients with chronic hepatitis B: Results of a phase I/II clinical trial. , 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA 29 Oct-2 Nov 2004 (Published in Hepatology) . 2004, 40(4): 173A. (Publication No. : 105354) Liu C.L., Fan S.T., Lo C.M., Wei W.I., Chan S.C., Yong B.H., Lai C.L. and Wong J., Operative outcomes of adult-to-adult right lobe live donor liver transplantation: a comparative study with cadaveric whole-graft liver transplantation in a single center (Abstract), The 20th International Congress of the Transplantation Society, Vienna, Austria, 5-10 September 2004. (Publication No. : 99614) Yuen R.M.F., Wong D.K.H., Sum S.M., Yuan H., Yuen J.C.H., Chan O.O., Wong B.C.Y. and Lai C.L., Effect of lamivudine therapy on the serum covalently closed circular DNA of chronic hepatitis B infection., 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA 29 Oct-2 Nov 2004 (Published in Hepatology). 2004, 40(4): 671A. (Publication No. : 105365) Yuen R.M.F., Kim J., Averett D., Wong D.K.H., Kim C.R., Kerr B., Ngai W.S., Yuen J.C.H. and Lai C.L., Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection., 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA 29 Oct-2 Nov 2004 (Published in Hepatology). 2004, 40 (4 Suppl 1): 172A. (Publication No. : 105328) Fan X.M., Zheng F.S., Liu H.Y., Ma Y.H., Yu H.F., Jiang M. and Wong B.C.Y., Inhibition of Akt/PKB-cytochrome c by a COX-2 inhibitor induced apoptosis of gastric cancer cell, Chinese Journal of Digestive Diseases. 2005, 6(Suppl 1): A62. (Publication No. : 99458) Wong B.C.Y., Targeting Inhibitor of Apoptosis proteins in tretment of cancer, Proceedings, Frontiers in Biomedical Research, The University of Hong Kong, Dec 2004. (Publication No. : 99426) Wong B.C.Y., Targeting the inhibitor of apoptosis proteins in cancer treatment, Proceedings, The Croucher Advanced Study Institute "Molecular genetics and cell signalling in cancers" January 17-21, 2005. (Publication No. : 99427) Lo C.M., Liu C.L., Lau G., Chan S.C., Ng I.O.L., Fan S.T. and Wong J., Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil to lamivudine (Poster Presentation), American Transplant Congress, Seattle, U.S.A., 21-25 May 2005. (Publication No. : 99909) Luk J.M.C., Wang P., Wang J., Lau G. and Fan S.T., Hepatocyte-like phenotypes of bone marrow stromal cells after co-culture with damaged liver tissues and intraportal transplantation in cirrhotic liver (Abstract), The 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA, 29 October – 2 November 2004. (Publication No. : 96566) Luk J.M.C., Lee C.K.F., Su Y.C.F., Lam C.T., Hu M.Y., He Q., Lau G., Wong W.S. and Fan S.T., Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma (Abstract), HUPO 3rd Annual World Congress, Beijing, China, 25-27 October 2004. (Publication No. : 96563) Luo Y., Lo C.M., Cheung C.K.Y., Lau G. and Fan S.T., Identification of hepatitis B virus specific lymphocytes in human liver allografts from hepatitis B virus immune donors (Abstract), The 6th Annual Scientific Meeting, Centre for the Study of Liver Disease, The University of Hong Kong, Hong Kong, 8 January 2005. (Publication No. : 99497) Luo Y., Lo C.M., Cheung C.K.Y., Lau G., Fan S.T. and Wong J., Potential role of resident intrahepatic lymphocytes in adoptive transfer of immunity to hepatitis B virus through liver transplantation (Poster Presentation), Digestive Disease Week, Chicago, U.S.A., 14-19 May 2004. (Publication No. : 99908) Ng S.M., Gao Y., Lum C.T., Yang Z.F., Huang J., Lau G., Fan S.T., Kung H. and Lin M.C., Novel gene therapy by rAAV-mediated transfer of human TERTC27 polypeptide in human and rat hepatocellular carcinomas, American Association for Cancer Research Meeting. 2004. (Publication No. : 106814) Ng S.S., Gao Y., Lum C.T., Yang Z., Huang J., Lau G., Fan S.T., Kung H. and Lin M.C., Novel HCC gene therapy by rAAV-mediated transfer of human TERTC27 polypeptide in human and rat hepatocellular carcinoma (Abstract), The 4th International Meeting on Hepatocellular Carcinoma: Eastern and Western Experiences, Hong Kong, 14-16 December 2004. (Publication No. : 99467) Ng S.S., Gao Y., Lum C.T., Yang Z., Lau G., Fan S.T., Kung H. and Lin M.C., rAAV-mediated long-term expression of endostatin significantly inhibits the progression of HCC (Abstract), The 4th International Meeting on Hepatocellular Carcinoma: Eastern and Western Experiences, Hong Kong, 14-16 December 2004. (Publication No. : 99475) Yong J.L., Lam C.M., Chan O.O., Poon R.T.P., Liu C.L., Lo C.M. and Fan S.T., Better survival in female patients with hepatocellular carcinoma (Abstract), The 4th International Meeting on Hepatocellular Carcinoma: Eastern and Western Experiences, Hong Kong, 14-16 December 2004. (Publication No. : 99466)
All other outputs

Lam S.K., Asian Pacific Working Party Meeting on Inflammatory Bowel Disease, Asian Pacific Digestive Week, Beijing (October 4-7, 2004). 2004. (Publication No. : 93651) Lam S.K., Presidential Paper Awards, Asian Pacific Digestive Week, Beijing (October 4-7, 2004). 2004. (Publication No. : 93652) Lai C.L. and Young R.T.T., Co-chaired the session of “Interpreting Abnormal Laboratory Findings†, 9th Hong Kong Medical Forum. 2004. (Publication No. : 101748) Lai C.L., Invited Co-Moderator for Symposium on “Infective Liver Disease – An Update of Epidemiology and Management†, Asian Pacific Disgestive Week 2004 . 2004. (Publication No. : 101791) Lai C.L., Member of the Editorial Board, World Journal of Gastroenterology. 2004. (Publication No. : 102505) Lai C.L., President, Medical Society, Hong Kong University Students' Union. 2005. (Publication No. : 102503) Lai C.L., Reviewer, Antiviral Research. 2004. (Publication No. : 102492) Lai C.L., Reviewer, CHBG Review. 2004. (Publication No. : 102502) Lai C.L., Reviewer, Carcinogenesis. 2004. (Publication No. : 102497) Lai C.L., Reviewer, Digestive and Liver Disease. 2004. (Publication No. : 102498) Lai C.L., Reviewer, Expert Opinion on Investigational Drugs. 2004. (Publication No. : 102499) Lai C.L., Reviewer, Gastroenterology. 2004. (Publication No. : 102491) Lai C.L., Reviewer, Hepatology. 2004. (Publication No. : 102496) Lai C.L., Reviewer, Journal of Gastroenterology and Hepatology. 2004. (Publication No. : 102501) Lai C.L., Reviewer, Journal of Infectious Diseases. 2004. (Publication No. : 102487) Lai C.L., Reviewer, Journal of Medical Virology. 2004. (Publication No. : 102489) Lai C.L., Reviewer, Journal of Viral Hepatitis. 2004. (Publication No. : 102488) Lai C.L., Reviewer, NIDDK. 2004. (Publication No. : 102494) Lai C.L., Reviewer, NMRC. 2004. (Publication No. : 102500) Lai C.L., Reviewer, New England Journal of Medicine. 2004. (Publication No. : 102493) Lai C.L., Reviewer, The Lancet. 2004. (Publication No. : 102495) Lai C.L., Reviewer, Vaccine. 2004. (Publication No. : 102490) Wong B.C.Y., Belching and dyspepsia, Mingpao, 1 Sept 2004 . Hong Kong, 2004, D5. (Publication No. : 106937) Wong B.C.Y., Cancer and Health Expo, Hong Kong Commercial News, 19 Dec 2004. Hong Kong, C1. (Publication No. : 106975) Wong B.C.Y., Clonochis sinesis, Mingpao, 4 Nov 2004. Hong Kong, A18. (Publication No. : 106945) Wong B.C.Y., Colon Cancer, Economy Daily, 9 Aug 2004 . Hong Hong, 2004, A4. (Publication No. : 106808) Wong B.C.Y., Colon cancer screening, Mingpao, 23 Aug 2004 . Hong Kong, 2004, D07. (Publication No. : 106935) Wong B.C.Y., Colon cancer, Oriental Daily, 18 Aug 2004. Hong Kong, A35. (Publication No. : 106933) Wong B.C.Y., Colon cancer, Sing Pao, 9 Aug 2004 . Hong Kong, 2004, A2. (Publication No. : 106928) Wong B.C.Y., Coloon cancer incidence on rising, Sing Pao, 6 Dec 2004. Hong Kong, A12. (Publication No. : 106948) Wong B.C.Y., Colouring of urine and stool, Sun, 24 Oct 2004. Hong Kong, A4. (Publication No. : 106947) Wong B.C.Y., Common GI problems in Hong Kong, Parents, Sept 2004 . Hong Kong, 2004, 148: 70-71. (Publication No. : 106938) Wong B.C.Y., Constipation, Mingpao, 28 Sept 2004. Hong Kong. (Publication No. : 106941) Wong B.C.Y., Dye in foood substances, Oriental Daily, 4 Oct 2004. Hong Kong, A24. (Publication No. : 106946) Wong B.C.Y., Dyspepsia and belching, Hong Kong Economic Times, 15 April 2005. Hong Kong, A22. (Publication No. : 106981) Wong B.C.Y., Early detection of colon cancer, Next Magazine, 9 Sept 2004. Hong Kong, 757: 138-139. (Publication No. : 106939) Wong B.C.Y., Expanding the horizons of small bowel endoscopy, Medical Tribune, Nov 2004. Hong Kong, i. (Publication No. : 106973) Wong B.C.Y., Expert advise colon cancer screening, Oriental Daily, 6 Dec 2004. Hong Kong, A18. (Publication No. : 106963) Wong B.C.Y., Faecal occult blood, Sun, 6 Dec 2004. Hong Kong, A22. (Publication No. : 106966) Wong B.C.Y., Fatal cases of Hepatitis E in Japan, Mingpao, 14 Dec 2004. Hong Kong, A18. (Publication No. : 106969) Wong B.C.Y., GERD prevalence rising, Medical Tribune, Oct 2004. Hong Kong. (Publication No. : 106944) Wong B.C.Y., GERD, Singtao, 23 Aug 2004. Hong Kong, E6. (Publication No. : 106936) Wong B.C.Y., Getting the word out on GERD, Doctor. Hong Kong, 2004, 5:9: 8. (Publication No. : 106942) Wong B.C.Y., Proton pump inhibitor best therapy for GERD, Medical Tribune, Sept 2004. Hong Kong, 7. (Publication No. : 106943) Wong B.C.Y., Screening for colon cancer, Sing Tao Daily News, 21 Dec 2004. Hong Kong, E7. (Publication No. : 106978) Wong B.C.Y., Screening of colon cancer, Metro Daily, 17 Sept 2004. Hong Kong, 30. (Publication No. : 106940) Wong B.C.Y., Suggest colon cancer screening, Apple Daily, 6 Dec 2004 . Hong Kong, 2004, A17. (Publication No. : 106958) Wong B.C.Y., Fong D.Y.T. and Karlberg J.P.E., Translation of the Rome II Modular Questionnaire, AstraZeneca AB. 2005. (Publication No. : 100858)
Editorship, Invited lectures and keynote speeches

Lam S.K., Epidemiology of GERD in the Asian Pacific Region, 19th World Congress of International Society for Digestive Surgery, Yokohama (December 8-11, 2004). 2004. (Publication No. : 96451) Lam S.K., Eradication of H. pylori and Gastric Cancer Experience in Fujian Province, China, Asia Pacific Digestive Week, Beijing (October 4-7, 2004). 2004. (Publication No. : 93637) Lam S.K., Pathogenesis of Gastric Cancer – A Unifying Concept, Frontiers in Biomedical Research – Clinical Applications, Beijing (December 6, 2004). 2004. (Publication No. : 96450) Lam S.K., The Genes & Pathologies of the Gastric Cancer Assembly, Asian Pacific Digestive Week, Beijing (October 4-7, 2004). 2004. (Publication No. : 93641) Lam S.K., The Status and Perspective of Gastric Diseases in Asia, Asian Pacific Digestive Week, Beijing (October 4-7, 2004). 2004. (Publication No. : 93643) Lai C.L., Adefovir as First Line Nucleoside Analogue for Chronic Hepatitis B: PRO, Asian Pacific Association for the Study Liver -2004 Conference. 2004. (Publication No. : 101812) Lai C.L., Advances in Treatment of Hepatiits B Infection, Alimentary Disease Weekend. 2004. (Publication No. : 101750) Lai C.L., Chemoprophylaxis for Hepatocellular Carcinoma, 4th International Meeting on HCC: East & Western Experiences. 2004. (Publication No. : 101804) Lai C.L., Chronic B Hepatitis, Management and Research Updated, Continuous Medical Education in Internal Medicine 2004/2005 organized by Serviços de Saúde of Governo da Região Administrativa Especial de Macau, Macau. 2005. (Publication No. : 101821) Lai C.L., Cirrhosis and carcinoma: what are the predictors of progression?†at the BMS supported, CME-accredited symposium “Building new strategies in chronic hepatitis B, 55th Annual Meeting of the American Association for the Study of Liver Disease . 2004. (Publication No. : 101801) Lai C.L., Editor for Hepatology, Journal of Gastroenterology and Hepatology. 2005. (Publication No. : 102504) Lai C.L., Emerging Therapeutic Problems in Chronic Hepatitis B – A New Treatment Option for HBeAg-negative Patients, Asian Pacific Association for the Study Liver -2004 conference . 2004. (Publication No. : 101816) Lai C.L. and Yuen R.M.F., Interpreting Abnormal Laboratory Findings: Liver Function , 9th Hong Kong Medical Forum. 2004. (Publication No. : 101710) Lai C.L., Liver cancer, Cancer Prevention and Health – Expo 2004 organised by Lions Club of Hong Kong. 2004. (Publication No. : 101810) Lai C.L., Liver cirrhosis and liver cancer, International Forum on Liver Fibrosis 2004. (Publication No. : 101806) Lai C.L., Management of Asymptomatic HBsAg-positive Subjects with Normal ALT and HBV DNA >100000 copies/ml, Asian Pacific Association for the Study Liver -2004 Conference. 2004. (Publication No. : 101813) Lai C.L., Management of Chronic Hepatitis B and Update on Entecaivr, BMS Satellite Symposium, KASL Spring Congress 2005. (Publication No. : 101830) Lai C.L., Management of Chronic Hepatitis B and Update on Entecavir Global Studies, BMS Satellite Symposium at the 12th National Congress for Viral Hepatitis and Liver Diseases . 2005. (Publication No. : 101826) Lai C.L., New Antiviral Agents for Chronic Hepatitis B†at the Meet-the-Expert session, Asian Pacific Association for the Study Liver -2004 conference. 2004. (Publication No. : 101819) Lai C.L., New Insights in Antiviral Treatment of Chronic Hepatitis B, Asian Pacific Digestive Week. 2004. (Publication No. : 101751) Lai C.L., Review/Critique of studies on natural history of hepatitis B, AASLD-APASL Research Workshop on Epidemiology and Natural History of Liver Diseases in Asia. 2004. (Publication No. : 101818) Lai C.L., Treatment of HBV Infection, the seminar on viral hepatitis for nurses 2005 organized by Department of Health, Hong Kong . 2005. (Publication No. : 101824) Lai C.L., Update on the Nature History of Chronic Hepatitis B , 9th Hong Kong Medical Forum. 2004. (Publication No. : 101721) Lai C.L., “New Insights in Antiviral Treatment of Chronic Hepatitis B†at the Continuing Education Seminar, “Lamivudine, Adefovir and New Antiviral Agents†organized by Pharmacy Central Continuing Education Committee. 2004. (Publication No. : 101805) Wong B.C.Y., Associate Editor, since 2004, Digestive Disease Watch. 2005. (Publication No. : 106988) Wong B.C.Y., Associate Editor-in-chief, Chinese Journal of Gastroenterology. 2004. (Publication No. : 106986) Wong B.C.Y., Associate Editor-in-chief, Chinese Journal of Gastroenterology. 2005. (Publication No. : 108183) Wong B.C.Y., Chemoprevention of colorectal cancer. , Asia Pacific Digestive Week, Beijing, PR China, October 5,. 2004. (Publication No. : 99734) Wong B.C.Y., Colorectal and gastric cancer screening in Hong Kong, International Conference of Cancer Screening in Asia, Keelong, Taiwan, Oct 26. 2004. (Publication No. : 99742) Wong B.C.Y., Common gastrointestinal diseases, Luncheon Meeting organised by Lions Club of Victoria Hong Kong, 12 Jan . 2005. (Publication No. : 106993) Wong B.C.Y., Controversies in Helicobacter pylori infection , In: , Keynote Lecture, First Guangdong Gastroenterology Meeting, Guangzhou, July 30. 2004. (Publication No. : 99730) Wong B.C.Y., Diagnosis and Management of resistant Helicobacter pylori infection, 62nd Hong Kong Doctors Union Sunday Symposium, October 17 . 2004. (Publication No. : 99740) Wong B.C.Y., Diet and GI diseases, Digestive Health Awareness Coalition Program for the Family Planning Association of HK (FPA), FPA auditorium, Wanchai, Hong Kong, April 22. 2005. (Publication No. : 99751) Wong B.C.Y., Editor, Journal of Gastroenterology and Hepatology. 2005. (Publication No. : 106959) Wong B.C.Y., Editorial Board, Alimentary Pharmacology and Therapeutics, since 2004. 2005. (Publication No. : 108192) Wong B.C.Y., Editorial Board, Carcinogenesis, since 2005. (Publication No. : 108197) Wong B.C.Y., Editorial Board, Chinese Journal of Digestive Diseases, since 2002. 2005. (Publication No. : 108186) Wong B.C.Y., Editorial Board, Digestive Endoscopy, since 2001. 2005. (Publication No. : 108185) Wong B.C.Y., Editorial Board, European Review for Medical and Pharmacological Sciences, since 2004. 2005. (Publication No. : 108190) Wong B.C.Y., Editorial Board, Gastrointestinal endoscopy, since 2004. 2005. (Publication No. : 108196) Wong B.C.Y., Editorial Board, Journal of Clinical Oncology, Chinese edition, since 1999.. 2005. (Publication No. : 108184) Wong B.C.Y., Editorial Board, MIMS Gastroenterology Guide, since 2002. 2005. (Publication No. : 108187) Wong B.C.Y., Editorial Board, Modern Digestion and Intervention, since 2003. 2005. (Publication No. : 108188) Wong B.C.Y., Editorial Board, World Journal of Gastroenterology, since 2004. 2005. (Publication No. : 108195) Wong B.C.Y., First, second and third line treatment of Helicobacter pylori infection, and capsule endoscopy , Annual refresher course, Hong Kong College of Family Physicians, Dec 10 . 2004. (Publication No. : 99747) Wong B.C.Y., From aspirin to apoptosis: Prevention and treatment of GI cancers, Peking University First Hospital, Beijing, PR China, 10 March . 2005. (Publication No. : 99750) Wong B.C.Y., Functional dyspepsia – pH, Hp or more? , Asia Pacific Digestive Week, Beijing, PR China, October 5. 2004. (Publication No. : 99733) Wong B.C.Y., GERD rising trend in Hong Kong, Press Conference, 12 Aug 2004. Hong Wong B.C.Y., GERD: Defining the standards of management , Symposium of Hong Kong Society of Gastroenterology and Hong Kong Society of Digestive Endoscopy, Hong Kong. April 25 . 2005. (Publication No. : 99752) Wong B.C.Y., Gastric cancer, Meet-the-Professor Luncheon, Digestive Disease Week, Chicago, USA, 18 May. 2005. (Publication No. : 99755) Wong B.C.Y., Guaiac vs. I-FOBTs screening experience, OMED Colorectal Cancer Screening Meeting, Chicago, USA, 15 May. 2005. (Publication No. : 99754) Wong B.C.Y., H pylori and GU/PU healing: new treatment options, Astrazeneca symposium on Nexium: maximize clinical benefits. Asia Pacific Digestive Week, Beijing, PR China, October 5 . 2004. (Publication No. : 99738) Wong B.C.Y., Helicobacter pylori and gastric cancer , 3rd Digestive Disease Seminar, Hyogo College of Medicine, Hyogo, Japan, Nov 18. 2004. (Publication No. : 99744) Wong B.C.Y., Helicobacter pylori and gastric cancer , In: Caritus Medical Center 40th Anniversary Scientific Symposium, Hong Kong, Nov 20. 2004. (Publication No. : 99745) Wong B.C.Y., Helicobacter pylori and gastric cancer , Medical Forum China, Fourth Medical Military University, Xian, China, July 20. 2004. (Publication No. : 99729) Wong B.C.Y., Helicobacter pylori and gastric cancer- the final story?, Alimentary Disease Weekend, The University of Hong Kong, Hong Kong, Sept 19. 2004. (Publication No. : 99732) Wong B.C.Y., Helicobacter pylori infection – to treat everyone? , 9th Hong Kong Medical Forum, Department of Medicine, The University of Hong Kong, July 18. 2004. (Publication No. : 99728) Wong B.C.Y., Helicobacter pylori infection, An invited talk organised by Lions Club of Central, Hong Kong, 19 Aug 2004. (Publication No. : 106934) Wong B.C.Y., Intervention Studies of gastric cancer , 5th Western Pacific Helicobacter Pylori Congress, Japan, November 18. 2004. (Publication No. : 99743) Wong B.C.Y., Intervention study on Helicobacter pylori and gastric cancer , 6th International Gastric Cancer Congress, Yokohama, Japan, 5 May. 2005. (Publication No. : 99753) Wong B.C.Y., Management of resistant Helicobacter pylori infection , Joint Thailand and Myanmar Gastroenterology Meeting, Myanmar, August 1 . 2004. (Publication No. : Wong B.C.Y., Prevention of gastric cancer , 5th Joint Annual Scientific Meeting, Hong Kong Society of Gastroenterology, Hong Kong, October 9. 2004. (Publication No. : 99739) Wong B.C.Y., Randomized controlled trials, In APAGE/OMGE training workshop on clinical research methods. Post-graduate course, Asia Pacific Digestive Week, Beijing, PR China, October 4. 2004. (Publication No. : 99737) Wong B.C.Y., Recent advances in screening and treatment of colon cancer for primary care physicians , Hong Kong College of Family Physicians Meeting, Hong Kong, 29 June. 2005. (Publication No. : 99756) Wong B.C.Y., Targeting COX-2 in prevention and treatment of GI cancers, Genomics, Proteomics and Therapeutics in Cancer Research, Faculty of Medicine, The University of Hong Kong, Hong Kong, October 20-21 . 2004. (Publication No. : 99741) Wong B.C.Y., Targeting Inhibitors of apoptosis in cancer treatment , Frontiers in biomedical research, Faculty of Medicine, The University of Hong Kong, Dec 3-4. 2004. (Publication No. : 99746) Wong B.C.Y., Targeting the inhibitor of apoptosis proteins in cancer treatment, The Croucher Advanced Study Institute "Molecular genetics and cell signalling in cancers" January 17-21. 2005. (Publication No. : 99749) Wong B.C.Y., Update on medical management of inflammatory bowel diseases, Hong Kong Surgical Forum, July 10 . 2004. (Publication No. : 99690) Wong B.C.Y., Validating RDQ in the diagnosis of GERD. , GI Summit, Astrazeneca, Beijing, PR China, October 3 . 2004. (Publication No. : 99735) Wong B.C.Y., Wireless pH monitoring: its technology and application , GI Summit, Astrazeneca, Beijing, PR China, October 3. 2004. (Publication No. : 99736) Lau G., 3rd Annual Clinical Options for Hepatitis Symposium, New Data on HBV Treatment. 2005. (Publication No. : 113565) Lau G., Associate Editor, Journal of Hepatology. 2004. (Publication No. : 113485) Lau G., Chronic Hepatitis B: Consolidating clinical knowledge for improved outcomes, American Association for the Study of Liver Diseases 2004. (Publication No. : 113572) Lau G., Hepatitis B treatment, Australian Hepatitis B Summit. 2005. (Publication No. : Lau G., I. Hepatitis B Virus and hepatocellular carcinoma (Plenary) II. Treatment of eAg-positive Chronic Hepatitis B†and “Interferons as First-line Therapy for Hepatitis B (Plenary) III. Interferons as first-line therapy for hepatitis B , Gulf HBV Symposium . 2005. (Publication No. : 113567) Lau G., Immunopathology of HBV infection and its impact on HBV variant selection, Foundation Merieux-Emerging Variants on hepatitis B virus, from research to the clinic. 2005. (Publication No. : 113569) Lau G., Importance of viral suppression in HBV infection, Asian Pacific Association for the Study of the Liver (APASL) 2004. (Publication No. : 113571) Lau G., State-of-the-Art lecture- Treatment of Chronic HBV Infection, Romanian National Gastroenterology and Hepatology Congress 2005. (Publication No. : 113566) Yuen R.M.F., HBeAg+ & HBeAg- chronic hepatitis B – how to treat? , Joint HKMA-HKASLD CME course in chronic hepatitis B management, Hong Kong. 2005. (Publication No. : 106686) Yuen R.M.F., HBsAg Seroclearance in Chronic Hepatitis B in The Chinese: Virological, Histologic and Clinical Aspects, Joint Scientific Meeting, Hong Kong College of Physicians, Hong Kong . 2004. (Publication No. : 106653) Yuen R.M.F., Interpreting abnormal laboratory findings, 9th Hong Kong Medical Forum (9th HKMF) Hong Kong Convention and Exhibition Centre . 2004. (Publication No. : 106646) Yuen R.M.F., Member of Editorial Board, Journal of Gastroenterology and Hepatology. Blackwell, 2005. (Publication No. : 112953) Yuen R.M.F., Member of Editorial Board, World Journal of Gastroenterology. Elsevier, 2005. (Publication No. : 112956) Yuen R.M.F., Preventing disease progression in chronic hepatitis B, Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology, The Andaman Langkawi, Pulau Langkawi, Malaysia. 2005. (Publication No. : 106689) Yuen R.M.F., Recent advances in chronic hepatitis B, The sixth joint scientific meeting, The Hong Kong Society of Gastroenterology, Hong Kong Society of Digestive Endoscopy, Hong Kong Society for Coloproctology, The Hong Kong Association for the Study of Liver Diseases, and The Hong Kong Society of Gastrointestinal Motility. Hong Kong. 2004. (Publication No. : 106655) Yuen R.M.F., Screening for hepatocellular carcinoma – State-of-the-Art Lecture, CSLD 6th annual scientific meeting. Hong Kong. 2005. (Publication No. : 106683) Yuen R.M.F., Update in the management of chronic viral hepatitis – chronic hepatitis B, 2004 autumn meeting of the Korean association for the study of the liver. Seoul, South Korea. 2004. (Publication No. : 106679)
Prizes and awards

Lai C.L., Outstanding Researcher Award, The University of Hong Kong. 2004. (Publication No. : 103523) Yuen R.M.F., Distinguished Research Paper Award for Young Investigators, Hong Kong College of Physicians . 2004. (Publication No. : 106009)

Source: http://www.medic.hku.hk/publication/gi&liver2004-05.pdf

Feature 1 r bruno.qxp

New Inhaled Liposomal Cyclosporine A Formulation Gives Hope For Lung Transplant RecipientsLow-dose inhaled L-CsA formulation improves the pharmacologic profile, thehighly variable bioavailability, and the severe side effects of oral CsA. According to the International Society of Heart and Lung and Pulmonary Drug Delivery features positive phase-1BTransplantation Registry, development of bronchiol

Neurologist-in-training

The aim of this section is to prepare the neuro- everyday neurological practice and to give him logist-in-training for the FMH examination, toor her updates on recent controversies in clinicalconfront her or him with specific problems ofContributions and correspondence to PD Dr. med. Hans H. Jung, Depar tment of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, CH-8091 Zurich, ha

Copyright ©2010-2018 Medical Science